Mathilde Guérin
Impact in
- Biotechnology top 2%
- Listeria monocytogenes in Food Safety
- Microbial Inactivation Methods
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 9
- HER2/EGFR in Cancer Research 4
- Cancer Immunotherapy and Biomarkers 3
- Cancer Treatment and Pharmacology 2
-
- Renal cell carcinoma treatment 3
- Co-authors
- Gwénaëlle Gravis (8 shared papers)Jochen Christoph Walz (8 shared papers)Naji Salem (5 shared papers)Jeanne Thomassin Piana (3 shared papers)Christine L. Pasero (2 shared papers)Daniel Olive (2 shared papers)Samuel Granjeaud (3 shared papers)Palma Rocchi (2 shared papers)
In The Last Decade
Mathilde Guérin
18 papers receiving 907 citations
Mathilde Guérin's Hit Papers
Peers
Comparison fields: 5 of 89
- Biotechnology 260
- Immunology 246
- Oncology 254
- Microbiology 53
- Food Science 148
Countries citing papers authored by Mathilde Guérin
This map shows the geographic impact of Mathilde Guérin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Guérin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Guérin more than expected).
Fields of papers citing papers by Mathilde Guérin
This network shows the impact of papers produced by Mathilde Guérin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Guérin. The network helps show where Mathilde Guérin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathilde Guérin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study Hit paper breakdown → | 2017 | 391 |
| 2 | 2016 | 171 | |
| 3 | 2015 | 162 | |
| 4 | 2017 | 53 | |
| 5 | 2020 | 30 | |
| 6 | 2019 | 17 | |
| 7 | 2018 | 16 | |
| 8 | 2019 | 15 | |
| 9 | 2025 | 13 | |
| 10 | 2015 | 13 | |
| 11 | 2016 | 12 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 9 | |
| 14 | 2022 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2012 | 4 | |
| 17 | 2013 | 3 | |
| 18 | 2024 | 1 | |
| 19 | 2025 | 0 |
About Mathilde Guérin
Mathilde Guérin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research and Immunology, having authored 19 papers that have together received 928 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Renal cell carcinoma treatment (3 papers), T-cell and B-cell Immunology (2 papers), Cancer Treatment and Pharmacology (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Biotechnology (260 citations), Immunology (246 citations), Oncology (254 citations), Microbiology (53 citations) and Food Science (148 citations). Mathilde Guérin has collaborated with scholars based in France, Italy and China. Frequent co-authors include Gwénaëlle Gravis, Jochen Christoph Walz, Naji Salem, Jeanne Thomassin Piana, Christine L. Pasero, Daniel Olive, Samuel Granjeaud, Palma Rocchi, Alessandro Moretta and Anthony Gonçalvès. Their work appears in journals such as Frontiers in Oncology, World Journal of Urology, Oncotarget, Cancer Treatment Reviews and Science China Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.